HOME >> BIOLOGY >> NEWS
Inflammation and drugs to control this activity studied in a variety of tumors sites

WASHINGTON, D.C. - Inflammation cuts both ways. When invaded by an infectious agent, for example, the body calls on the forces of inflammation to fight and defeat the intruder. But when the biochemical processes of the immune system are either misdirected or chronically turned on, inflammation can lead to adversity, including some forms of cancer. For this reason, scientists are closely studying the link between inflammatory processes and tumor formation, while others are investigating anti-inflammatory drugs as a means to prevent and treat cancer, as seen by studies presented today at the 97th Annual Meeting of the American Association for Cancer Research.

Antihistamine and Anti-inflammatory Drug Use Associated Differently for High-Grade Versus Low-Grade Gliomas: Abstract No. 486

Individuals who used antihistamines regularly for a six-month period or longer have nearly a three-fold greater risk of developing mid-grade brain tumors, and a two-fold risk of having low-grade tumors. Using anti-inflammatory medications helped protect against developing a deadly brain tumor called glioblastoma.

The researchers, led by Michael Scheurer, Ph.D., postdoctoral fellow in Cancer Prevention and Melissa Bondy, Ph.D., professor of Epidemiology, both at The University of Texas M. D. Anderson Cancer Center in Houston, cautioned that they are not implying that use of antihistamines causes brain tumors, but rather that these medications may be part of a complex milieu of factors that contribute to their development.

Scheurer and Bondy used combined data from two studies: the Harris County Adult Glioma Study and the Bay Area Adult Glioma Study, led by Margaret Wrensch, Ph.D. at the University of California, San Francisco. As part of the studies, participants were asked about their use of antihistamines and anti-inflammatory drugs.

They compared antihistamine and anti-inflammatory drug use in 830 brain tumor cases and 831 controls m
'"/>

Contact: Warren R. Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
4-Apr-2006


Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. Inflammation may cause preterm labor and fetal deaths
2. Inflammation is at the origin and progression of diseases such as diabetes or cancer
3. Targeting tau: Inflammation study suggests new approach for fighting Alzheimers
4. Inflammation markers identify fatigue in breast cancer survivors
5. MIT model could predict cells response to drugs
6. New target for HIV/AIDS drugs and vaccine discovered
7. Modified mushrooms may yield human drugs
8. UGR researchers design an alternative to blood test to detect drugs in the body
9. Could fungal collection hold the key to new life-saving drugs?
10. Sensitivity to diverse range of chemotherapeutic drugs linked to common pathway
11. Scientists develop new drugs to fight colon and breast cancer more effectively

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2018)... Texas (PRWEB) , ... July 31, 2018 , ... ... supplier, welcomes William “Will” Muzek as Business Development Manager. In this role, Mr. ... goals and to accelerate Lifecycle’s continued growth and expansion. , With over ...
(Date:7/28/2018)... ... ... Inthirani Arul, an evidence-based healer, today announces research results based on the impact ... , Biomarkers for immune function, blood, as well as, inflammation, were assessed in the ... overall immunity as seen by the rise in antibody levels , Over ...
(Date:7/26/2018)... ... July 26, 2018 , ... Shirley Holmlund, ... impact of biofield energy healing treated Vitamin D3 on the strength and health ... levels, over 290% improvement in bone mineralization and over 100% increase in ALP, ...
Breaking Biology News(10 mins):
(Date:8/9/2018)... ... , ... ActX introduces GenoACT(sm), a Genetic Clinical Decision Support ... scientific team that includes geneticists, PharmD’s, genetic counselors, and physicians aided by machine ... impact of a patient’s genetic variants , 2. Educational information for clinicians, with ...
(Date:8/9/2018)... ... August 09, 2018 , ... ... engineering, and construction (AEC) experts with building owners and managers for a full-day ... Create + Construct symposium comes to Boston for the first time on Thursday, ...
(Date:7/31/2018)... ... July 31, 2018 , ... ZeptoMetrix™ Corporation (ZMC) ... its expanding CE/IVD product inventory. , “We are pleased today to introduce two ... remains entirely committed to fully support and provide our diagnostics industry with as ...
(Date:7/25/2018)... ... 25, 2018 , ... Dimitrius Anagnos, an evidence-based healer, today ... and autoimmune disorders. , The preclinical research assessed biomarkers for systemic and ... Over 70% decrease in Interleukin (IL-1ß) expression , ...
Breaking Biology Technology:
Cached News: